A Rare Breakthrough in the Treatment of Colorectal Cancer Patients Harboring a KRAS mutation.
March 7, 2023
Read More
NEXT-Virginia Opens Phase I Clinical Research Clinic for Oncology Patients in collaboration with Virginia Cancer Specialists
January 10, 2023
Read More
Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial
June 27, 2022
Read More
Molecular Tumor Board offer patients diagnosed with cancer access to personalized medicine - Timothy A. McCarthy, MD
December 9, 2021
Read More
Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials
October 11, 2021
Read More
Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership
October 6, 2021
Read More
Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients
February 4, 2021
Read More
Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial
April 9, 2020
Read More